Financial Ratios Zurich Insurance Group Ltd
Equities
ZURN
CH0011075394
Multiline Insurance & Brokers
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 583.80 CHF | +0.07% |
|
+1.46% | +8.35% |
| Dec. 08 | ZURICH INSURANCE GROUP : Sell rating from JP Morgan | ZD |
| Dec. 08 | Swiss stocks - Factors to watch on December 8 | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.85 | 1.14 | 1.03 | 3.23 | 1.53 | |||||
Return on Total Capital | 6.63 | 8.73 | 8.18 | 26.08 | 12.93 | |||||
Return On Equity % | 10.66 | 13.73 | 14.67 | 17.73 | 23.32 | |||||
Return on Common Equity | 10.46 | 13.66 | 14.27 | 17.22 | 23.1 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 23.31 | 23.94 | 36.51 | 32.52 | 22.16 | |||||
SG&A Margin | 13.58 | 12.55 | 20.61 | 4.8 | 5.2 | |||||
EBITDA Margin % | 10.13 | 11.78 | 16.51 | 24.4 | 13.15 | |||||
EBITA Margin % | 9.95 | 11.59 | 16.23 | 24.23 | 12.98 | |||||
EBIT Margin % | 9.73 | 11.38 | 15.9 | 24.07 | 12.79 | |||||
Income From Continuing Operations Margin % | 6.91 | 7.74 | 11.71 | 6.32 | 9.03 | |||||
Net Income Margin % | 6.5 | 7.43 | 10.95 | 5.83 | 8.46 | |||||
Net Avail. For Common Margin % | 6.5 | 7.43 | 10.95 | 5.83 | 8.46 | |||||
Normalized Net Income Margin | 5.26 | 6.38 | 8.53 | 5 | 7.03 | |||||
Levered Free Cash Flow Margin | 5.73 | 4.86 | -11.93 | -11.36 | 6.22 | |||||
Unlevered Free Cash Flow Margin | 6.15 | 5.28 | -11.28 | -1.81 | 6.62 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.14 | 0.16 | 0.1 | 0.21 | 0.19 | |||||
Fixed Assets Turnover | 22.08 | 27.25 | 18.04 | 34.6 | 34.71 | |||||
Receivables Turnover (Average Receivables) | 13.8 | 16.31 | 9.61 | 110.34 | 90.9 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.41 | 1.33 | 1.48 | 2.44 | 5.86 | |||||
Quick Ratio | 0.65 | 0.51 | 0.47 | 1.03 | 3.44 | |||||
Operating Cash Flow to Current Liabilities | 0.11 | 0.06 | 0.09 | 0.21 | 0.72 | |||||
Days Sales Outstanding (Average Receivables) | 26.53 | 22.38 | 37.99 | 3.31 | 4.03 | |||||
Average Days Payable Outstanding | 141.3 | 117.48 | 133.27 | 5.38 | 4.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 42.04 | 46.89 | 59.97 | 61.7 | 57.73 | |||||
Total Debt / Total Capital | 29.6 | 31.92 | 37.49 | 38.16 | 36.6 | |||||
LT Debt/Equity | 38.5 | 41.33 | 53.94 | 53.07 | 51.1 | |||||
Long-Term Debt / Total Capital | 27.1 | 28.14 | 33.72 | 32.82 | 32.39 | |||||
Total Liabilities / Total Assets | 90.93 | 91.01 | 92.61 | 92.73 | 92.48 | |||||
EBIT / Interest Expense | 14.38 | 17 | 15.4 | 1.57 | 19.98 | |||||
EBITDA / Interest Expense | 15.56 | 18.06 | 16.44 | 1.62 | 20.98 | |||||
(EBITDA - Capex) / Interest Expense | 14.18 | 16.83 | 15.12 | 1.58 | 20.14 | |||||
Total Debt / EBITDA | 2.7 | 2.17 | 2.35 | 0.88 | 1.68 | |||||
Net Debt / EBITDA | 0.98 | 1.19 | 1.34 | 0.5 | 0.98 | |||||
Total Debt / (EBITDA - Capex) | 2.96 | 2.33 | 2.55 | 0.9 | 1.76 | |||||
Net Debt / (EBITDA - Capex) | 1.08 | 1.27 | 1.46 | 0.52 | 1.03 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -18.23 | 18.84 | -39.99 | 27.38 | 7.83 | |||||
Gross Profit, 1 Yr. Growth % | -7.25 | 22.03 | -8.47 | 101.16 | 14.29 | |||||
EBITDA, 1 Yr. Growth % | -16.63 | 38.14 | -15.87 | 193.49 | 24.38 | |||||
EBITA, 1 Yr. Growth % | -16.64 | 38.51 | -15.97 | 197.05 | 25.07 | |||||
EBIT, 1 Yr. Growth % | -15.6 | 39.03 | -16.19 | 200.82 | 25.3 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -7.12 | 33.23 | -9.27 | 9.75 | 31.52 | |||||
Net Income, 1 Yr. Growth % | -7.55 | 35.68 | -11.51 | 9.76 | 33.62 | |||||
Normalized Net Income, 1 Yr. Growth % | -17.6 | 44.2 | -19.71 | 19.56 | 29.29 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -7.69 | 35.6 | -11.22 | 12.19 | 35.05 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.66 | -9.94 | -8.66 | -5.98 | -10.76 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.37 | 5.27 | 6.89 | -14.2 | 32.41 | |||||
Total Assets, 1 Yr. Growth % | 8.55 | -0.79 | -13.32 | 7.74 | -0.93 | |||||
Common Equity, 1 Yr. Growth % | 9.35 | -1.04 | -29.69 | -3.2 | 2.46 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.84 | -8.75 | -42.28 | -9.78 | 5.31 | |||||
Cash From Operations, 1 Yr. Growth % | 16.73 | -44.45 | 60.37 | 45.68 | 3.51 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.6 | 4.35 | -0.69 | -21.87 | -11.48 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -34.22 | 0.73 | -247.37 | -41.65 | -150.36 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -32.65 | 1.89 | -228.34 | -90.54 | -155.47 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.46 | 6.76 | 7.55 | 18.96 | 0.07 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.74 | -1.42 | -15.55 | 3.26 | 8.25 | |||||
Gross Profit, 2 Yr. CAGR % | 1.66 | 6.39 | 5.69 | 20.35 | 12.31 | |||||
EBITDA, 2 Yr. CAGR % | 0.25 | 7.32 | 7.81 | 48.63 | 20.61 | |||||
EBITA, 2 Yr. CAGR % | 0.84 | 7.46 | 7.88 | 49.27 | 21.01 | |||||
EBIT, 2 Yr. CAGR % | 1.79 | 8.33 | 7.95 | 50.15 | 21.28 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.19 | 11.24 | 9.94 | -6.75 | 20.14 | |||||
Net Income, 2 Yr. CAGR % | 1.58 | 12 | 9.57 | -8.54 | 21.11 | |||||
Normalized Net Income, 2 Yr. CAGR % | 2.51 | 9.01 | 7.6 | -8.56 | 24.33 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.46 | 11.88 | 9.72 | -7.38 | 23.09 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 61.51 | -3.85 | -9.31 | -7.33 | -8.4 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.76 | 0.87 | 6.07 | -62.82 | 6.59 | |||||
Total Assets, 2 Yr. CAGR % | 5.41 | 3.78 | -7.27 | -8.94 | 3.31 | |||||
Common Equity, 2 Yr. CAGR % | 12.6 | 4.03 | -16.59 | -18.99 | -0.41 | |||||
Tangible Book Value, 2 Yr. CAGR % | 14.24 | 0.57 | -27.43 | -29.44 | -2.53 | |||||
Cash From Operations, 2 Yr. CAGR % | 13.98 | -19.47 | -5.61 | 52.29 | 22.8 | |||||
Capital Expenditures, 2 Yr. CAGR % | -30.78 | -12.48 | 1.8 | -14.81 | -16.84 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -1.15 | -18.6 | 21.84 | 57.93 | -45.79 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -1.1 | -17.16 | 14.35 | -39.57 | -43.53 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.2 | 8.1 | 7.15 | 13.11 | 9.11 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.73 | 14.06 | -16.45 | 8.21 | -0.64 | |||||
Gross Profit, 3 Yr. CAGR % | 2.31 | 8.04 | 1.18 | 20.91 | -3.16 | |||||
EBITDA, 3 Yr. CAGR % | -0.13 | 11.56 | -1.04 | 45.05 | 3.07 | |||||
EBITA, 3 Yr. CAGR % | 0.11 | 12.09 | -1 | 45.6 | 3.18 | |||||
EBIT, 3 Yr. CAGR % | 0.68 | 12.94 | -0.55 | 46.35 | 3.3 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.16 | 10.9 | 3.93 | 5.02 | 4.57 | |||||
Net Income, 3 Yr. CAGR % | 8.47 | 11.87 | 3.54 | 4.31 | 3.78 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.64 | 14.86 | -1.55 | 6.43 | 2.63 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 8.7 | 11.76 | 3.58 | 5.17 | 5.02 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 41.19 | 32.93 | -5.48 | -8.21 | -8.49 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.64 | 2.25 | 2.84 | -47.4 | -43.22 | |||||
Total Assets, 3 Yr. CAGR % | 1.34 | 3.3 | -2.27 | -6.3 | -6.35 | |||||
Common Equity, 3 Yr. CAGR % | 5 | 7.86 | -8.71 | -13.4 | -12.39 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.89 | 6 | -16.42 | -23.13 | -19.36 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.07 | -10.3 | 1.31 | 8.81 | 33.9 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.36 | -20.63 | -8.72 | -8.85 | -13.72 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 14.16 | -0.53 | -0.79 | 35.95 | 7.9 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 12.8 | -0.11 | -4.15 | -28.08 | 7.17 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.97 | 7.72 | 7.92 | 10.95 | 8.59 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.54 | 0.79 | -8.08 | 9.61 | -0.95 | |||||
Gross Profit, 5 Yr. CAGR % | 2.04 | 4.73 | 3.65 | 12.81 | 0.55 | |||||
EBITDA, 5 Yr. CAGR % | 7.57 | 6.19 | 2.97 | 25.13 | 4.75 | |||||
EBITA, 5 Yr. CAGR % | 8.04 | 6.47 | 3.15 | 25.7 | 4.87 | |||||
EBIT, 5 Yr. CAGR % | 8.76 | 6.8 | 3.52 | 26.57 | 5.29 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.75 | 9.29 | 8.27 | 3.47 | 7.19 | |||||
Net Income, 5 Yr. CAGR % | 15.79 | 10.13 | 8.91 | 3.21 | 6.99 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.49 | 7.9 | 3.98 | 4.84 | 5.13 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 15.7 | 10.17 | 9.11 | 3.67 | 7.71 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 18.86 | 20.65 | 18.28 | 15.07 | -6.66 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.08 | 2.19 | 2.79 | -31.78 | -28.55 | |||||
Total Assets, 5 Yr. CAGR % | 2.84 | 2.65 | -2.19 | -1.78 | -2.42 | |||||
Common Equity, 5 Yr. CAGR % | 4.19 | 4.32 | -4.23 | -3.81 | -6.16 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.62 | 2.6 | -9.48 | -9.93 | -11.91 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.77 | 16.54 | -0.5 | 10.85 | 9.26 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.03 | -4.23 | 1.54 | -18.35 | -13.22 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.75 | -4.68 | 17.17 | 19.68 | -3.6 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.17 | -4.23 | 13.42 | -18.3 | -3.32 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.89 | 7.6 | 7.04 | 9.84 | 8.39 |
- Stock Market
- Equities
- ZURN Stock
- Financials Zurich Insurance Group Ltd
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















